Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
17.42
+0.20 (1.16%)
At close: Nov 20, 2026, 4:00 PM EST
17.18
-0.24 (-1.38%)
After-hours: Nov 20, 2026, 7:44 PM EST
Carlsmed Revenue
Carlsmed had revenue of $21.55M in the quarter ending September 30, 2026, with 64.86% growth. This brings the company's total for the last twelve months to $71.78M, up 60.38% year-over-year. In the year 2025, Carlsmed had annual revenue of $50.51M with 85.94% growth. That makes Carlsmed the 25,297th largest company in the world by revenue and 3,516th in the United States.
Revenue (ttm)
$71.78M
Revenue Growth
+60.38%
P/S Ratio
6.65
Revenue / Employee
$565,157
Employees
127
Market Cap
477.38M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 50.51M | 23.35M | 85.94% |
| Dec 31, 2024 | 27.17M | 13.39M | 97.16% |
| Dec 31, 2023 | 13.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
CARL News
- 5 days ago - Carlsmed to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 10 days ago - Carlsmed price target raised to $23 from $20 at Truist - TheFly
- 10 days ago - Carlsmed price target raised to $26 from $24 at BTIG - TheFly
- 11 days ago - Carlsmed Earnings Call Transcript: Q3 2026 - Transcripts
- 11 days ago - Carlsmed Earnings release: Q3 2026 - Filings
- 11 days ago - Carlsmed Quarterly report: Q3 2026 - Filings
- 11 days ago - Carlsmed reports Q3 EPS (34c), consensus (38c) - TheFly
- 11 days ago - Carlsmed raises FY26 revenue view to $78M-$80M from $74M-$78M - TheFly